Skip to content
The Lancet: April 24, 2014 episode artwork

Apr 24, 2014 9 min

The Lancet: April 24, 2014

from Listen to The Lancet Hosted by The Lancet

Marcia Brose discusses results of a phase III trial of the kinase inhibitor sorafenib for treating radioactive iodine-refractory thyroid cancer.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The Lancet: April 24, 2014

0:00 9:23

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

French Your Way Jessica: Native French teacher founder of French Your Way Boost your French listening skills and test your comprehension with this one of a kind series of podcasts. Get the chance to listen to a real conversation between native speakers talking at normal speed AND customise your learning experience through carefully designed sets of questions (2 levels of difficulty) available for download at www.frenchvoicespodcast.com. All interviews also come with the transcript. French teacher Jessica interviews native speakers of French from around the world who share a bit of their life and passion. Where else would you meet in one same place a French yoga teacher based in Melbourne, a soap manufacturer from Provence, or a couple cycling around the world?

Frequently asked questions

How long is this episode of Listen to The Lancet?

This episode is 9 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on April 24, 2014.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.